Scrub Typhus

  • Author: David J Cennimo, MD, FAAP, FACP, AAHIVS; Chief Editor: Russell W Steele, MD  more...
Updated: Oct 01, 2015

Practice Essentials

Scrub typhus is an acute, febrile, infectious illness that is caused by Orientia tsutsugamushi. The name derives from the type of vegetation (ie, terrain between woods and clearings) that harbors the vector. The image below depicts a typical eschar seen in scrub typhus.

Typical eschar. Typical eschar.

Signs and symptoms

Elements brought out in the history may include the following:

  • Travel to an area where scrub typhus is endemic
  • Chigger bite (often painless and unnoticed)
  • Incubation period of 6-20 days (average, 10 days)
  • Headaches, shaking chills, lymphadenopathy, conjunctival injection, fever, anorexia, and general apathy
  • Rash; a small, painless, gradually enlarging papule, which leads to an area of central necrosis and is followed by eschar formation

Although many other conditions can present with a high fever, the presentation of the rash, a history of exposure to endemic areas, and the presentation of the sore caused by the bite can be diagnostic of scrub fever.

Physical findings may include the following:

  • Site of infection marked by a chigger bite
  • Eschar at the inoculation site (in about 50% of patients with primary infection and 30% of those with recurrent infection)
  • High fever (40-40.5°C [104-105°F]), occurring more than 98% of the time
  • Tender regional or generalized lymphadenopathy, occurring in 40-97% of cases
  • Less frequently, ocular pain, wet cough, malaise, and injected conjunctiva
  • Centrifugal macular rash on the trunk
  • Enlargement of the spleen, cough, and delirium
  • Pneumonitis or encephalitis
  • Central nervous system (CNS), pulmonary, or cardiac involvement
  • Rarely, acute renal failure, shock, and disseminated intravascular coagulation (DIC)

See Presentation for more detail.


Laboratory studies in patients with scrub typhus may reveal the following:

  • Early lymphopenia with late lymphocytosis
  • Decreased CD4:CD8 lymphocyte ratio
  • Thrombocytopenia
  • Hematologic manifestations may be confused with dengue infection
  • Elevated transaminase levels (75-95% of patients)
  • Hypoalbuminemia (50% of cases)

Laboratory studies of choice are serologic tests for antibodies, including the following:

  • Indirect immunoperoxidase test
  • Indirect fluorescent antibody test
  • Dot immunoassay
  • Rapid immunochromatographic tests for detection of IgM and IgG
  • Polymerase chain reaction (PCR) assay
  • Rapid diagnostic reagent for scrub typhus
  • Weil-Felix OX-K strain agglutination reaction

Chest radiography may reveal pneumonitis, especially in the lower lung fields.

See Workup for more detail.


Current treatment for scrub typhus is based on antibiotic therapy. Relapses may occur if the antibiotics are not taken for long enough. Agents that have been used include the following:

  • Tetracycline derivatives (standard; especially doxycycline)
  • Macrolides (eg, azithromycin, roxithromycin, and telithromycin)
  • Fluoroquinolones (not currently recommended; results have been mixed)

Diet and activity are as tolerated. Inpatient care may be necessary for patients with severe scrub typhus. In such cases, meticulous supportive management is necessary to abort progression to DIC or circulatory collapse.

Preventive measures in endemic areas include the following:

  • Protective clothing
  • Insect repellents
  • Short-term vector reduction using environmental insecticides and vegetation control

Chemoprophylaxis regimens have included the following:

  • A single dose of doxycycline given weekly, started before exposure and continued for 6 weeks after exposure [1]
  • A single oral dose of chloramphenicol (typically not used in the United States) or tetracycline given every 5 days for a total of 35 days, with 5-day nontreatment intervals

No vaccine is available.

See Treatment and Medication for more detail.



Scrub typhus is an acute, febrile, infectious illness that was first described in China in 313 AD. It is caused by Orientia (formerly Rickettsia) tsutsugamushi, an obligate intracellular gram-negative bacterium, which was first isolated in Japan in 1930. Although scrub typhus was originally recognized as one of the tropical rickettsial diseases, O tsutsugamushi differs from the rickettsiae with respect to cell-wall structure and genetic composition.

The term scrub typhus derives from the type of vegetation (ie, terrain between woods and clearings) that harbors the vector. However, this term is not entirely accurate, in that scrub typhus can also be prevalent in areas such as sandy beaches, mountain deserts, and equatorial rain forests.

US cases have been imported from regions of the “tsutsugamushi triangle,” which extends from northern Japan and eastern Russia in the north to northern Australia in the south and to Pakistan and Afghanistan in the west, where the disease is endemic. The range includes tropical and temperate regions, extending to altitudes greater than 3200 meters in the Himalayas. Scrub typhus is often acquired during occupational or agricultural exposures[2] because active rice fields are an important reservoir for transmission.[3]

Western medicine became especially interested in scrub typhus during military campaigns fought in East Asia. During World War II, 18,000 cases were observed in Allied troops stationed in rural or jungle areas of the Pacific theatre.[3] Scrub typhus was the second or third most common infection reported in US troops stationed in Vietnam[4] and still infects troops in the region.[5, 6] The US military continues to work on vector control, more accurate diagnostic tests, better vaccines, and improved surveillance methods.[7]

Currently, it is estimated that about 1 million cases of scrub typhus occur annually and that as many as 1 billion people living in endemic areas may have been infected by O tsutsugamushi at some time.[6] Because of reports of O tsutsugamushi strains with reduced susceptibility to antibiotics,[8] as well as reports of interesting interactions between this bacterium and HIV, a renewed interest in scrub typhus has emerged.[9, 10]



O tsutsugamushi, the pathogen that causes scrub typhus, is transmitted to humans through the bite of an infected chigger (see the image below), the larval stage of Leptotrombidium mites. These 6-legged, 0.2-mm larvae are not host specific and feed for 2-10 days on the skin fluids of the host. Wild rats serve as the natural reservoir for the chiggers (and represent a risk factor for human infection[2] ), but they are rarely infected with O tsutsugamushi.[3] When the chiggers feed on humans, infection occurs.

Chigger. Image taken from "Food and Environmental Chigger. Image taken from "Food and Environmental Hygiene Department" Web site and is reproduced under license from the Government of Hong Kong Special Administrative Region.

Orientia is also transmitted transovarially in mites and can unbalance the sex ratio of offspring in favor of females, further propagating infection.[3, 11] Chigger activity and subsequent human infection rates are determined by the particular Leptotrombidium species present (eg, akamushi, deliense, or pallidum), as well as by local conditions. Not surprisingly, positive correlations have been noted between chigger population abundance and human cases of scrub typhus.[12]

In tropical regions, scrub typhus may be acquired year round. In Japan, the chigger of Leptotrombidium akamushi is only active between July and September, when the temperature is above 25°C (77°F). In contrast, Leptotrombidium pallidum, which is found over a wide range, is active at temperatures of 18-20°C (64.4-68°F), from spring into early summer and autumn).[3, 13]

Humans acquire scrub typhus when an infected chigger bites them while feeding and inoculates O tsutsugamushi pathogens. The bacteria multiply at the inoculation site, and a papule forms that ulcerates and becomes necrotic, evolving into an eschar, with regional lymphadenopathy that may progress to generalized lymphadenopathy within a few days. In experimental infection, humans developed an acute febrile illness within 8-10 days of the chigger bite. Bacteremia was present 1-3 days before onset of fever.[14]

As in rickettsial diseases, perivasculitis of the small blood vessels occurs. The endothelium is involved; however, the basic histopathologic lesions suggest that macrophages might be more affected.[15]

O tsutsugamushi stimulates phagocytosis by the immune cells, and then escapes the phagosome. It replicates in the cytoplasm (see the image below) and then buds from the cell. The bacteria are able to harness the microtubule assembly inside the human cell for movement. Antibody-opsonized bacteria are still able to escape the phagosome but cannot effectively move on the microtubule; as a result, overall infectivity is decreased.[3]

Transmission electron micrograph depicts peritonea Transmission electron micrograph depicts peritoneal mesothelial cell of mouse that had been experimentally infected intraperitoneally with Orientia tsutsugamushi. Several organisms are visible within mesothelial cell's cytoplasm.

Scrub typhus may disseminate into multiple organs through endothelial cells and macrophages, resulting in the development of fatal complications.[16, 17] In 2009, an apparent association was reported apparent between high O tsutsugamushi blood polymerase chain reaction (PCR)-determined DNA loads and disease severity.[18]



Scrub typhus is caused by O tsutsugamushi, an obligate intracellular gram-negative bacterium that lives primarily in L akamushi and L deliense mites . This organism is found throughout the mite’s body but is present in the greatest number in the salivary glands. When the mite feeds on rodents (eg, rats, moles, and field mice, which are the secondary reservoirs) or humans, the parasites are transmitted to the host. Only larval Leptotrombidium mites (chiggers) transmit the disease.

O tsutsugamushi is very similar to the rickettsiae and indeed meets all of the classifications of the genus Rickettsia; this connection is demonstrated by the high degree of homology (90-99%) on 16S ribosomal sequencing. However, the cell walls are quite different, in that those of O tsutsugamushi lack peptidoglycan and lipopolysaccharide.[3] This pathogen does not have a vacuolar membrane; thus, it freely grows in the cytoplasm of infected cells.

There are numerous serotypes,[19] of which 5—Karp, Gilliam, Kawazaki, Boryon, and Kato—are helpful in serologic diagnosis. About half of isolates are seroreactive to Karp antisera, and approximately one-quarter of isolates are seroreactive to antisera against the prototype Gilliam strain.[20]

Risk factors

In 2009, behavioral factors were shown to be associated with scrub typhus during an autumn epidemic season in South Korea.[21] Taking a rest directly on the grass, working in short sleeves, working with bare hands, and squatting to defecate or urinate posed the highest risks. Wearing a long-sleeved shirt while working, keeping work clothes off the grass, and always using a mat to rest outdoors showed protective associations.



United States statistics

Scrub typhus has no significant presence in the United States itself. The only cases of scrub typhus reported in the United States derive from elsewhere—for example, US travelers who have recently been to one of the endemic areas, military personnel who have been stationed abroad, or persons who have emigrated from other countries.[13, 22]

International statistics

Scrub typhus is endemic in regions of eastern Asia and the southwestern Pacific (Korea to Australia) and from Japan to India and Pakistan.[2, 15, 23, 24, 25, 26]

It is generally a disease of rural villages and suburban areas and is normally not encountered in the cities.

Although most cases are undiagnosed, prospective studies in endemic areas reveal in incidence of 18-23%.[3, 27] Community surveys in Malaysia reported an incidence of 3.2-3.5% per month and a seroprevalence exceeding 80% in those older than 44 years.[28] Surveillance of military personal deployed in southeast Asia demonstrated seroconversion in 484 per 1000 population.[5]

The seasonal occurrence of scrub typhus varies with the climate in different countries because the mites are able to thrive as conditions change. The mites prefer the rainy season and certain areas (eg, forest clearings, riverbanks, and grassy regions). In the past few years, cases have been noted earlier in the season because of increased mite activity as the weather warms.[29] Areas in which mites thrive pose a greater risk to humans. The prevalence of scrub typhus in Japan has been rising, and much of the current research is based in Japan.

Age-, sex-, and race-related demographics

People of all ages are affected equally by scrub typhus. Men and women are affected with equal frequency. No race-related differences in incidence have been documented.



Prognosis varies and depends on the severity of illness, which relates to the different strains of O tsutsugamushi, as well as to host factors. Severe disease is uncommon with antimicrobial treatment. Prognostic indicators for severe disease have not been established.[30] Incomplete immunity and strain heterogeneity open the door to frequent reinfections. Immunity to the same strain is believed to last 3 years, whereas immunity to other strains may last as little as 1 month; however, repeat infections may be attenuated.[3]

In patients who are not treated, mortality ranges from 1% to 60%, depending on the patient’s age, the geographic area, and the particular strain responsible for the infection. In the preantibiotic era, mortality in Japan averaged 30%: 15% in patients aged 11-20 years, 20% in those aged 21-30 years, and 59% in those older than 60 years. In Taiwan, overall mortality was estimated at 11% but was only 5% in children and 45% in the elderly.

With appropriate antibiotic treatment, mortality from scrub typhus is quite rare, and the recovery period is short and usually without complications.[3, 29] However, mortality is still approximately 15% in some areas as a consequence of missed or delayed diagnosis.[31] If severe complications such as acute respiratory distress syndrome (ARDS) arise, mortality may still be high.[32]

Contributor Information and Disclosures

David J Cennimo, MD, FAAP, FACP, AAHIVS Assistant Professor of Medicine and Pediatrics, Adult and Pediatric Infectious Diseases, Director, Disease Processes, Prevention, and Therapeutics, Director, Pediatric Infectious Diseases Fellowship, Rutgers New Jersey Medical School

David J Cennimo, MD, FAAP, FACP, AAHIVS is a member of the following medical societies: American Academy of Pediatrics, American College of Physicians, American Medical Association, Infectious Diseases Society of America, Medical Society of New Jersey, Pediatric Infectious Diseases Society, HIV Medicine Association, American Academy of HIV Medicine

Disclosure: Nothing to disclose.


Arry Dieudonne, MD Associate Professor of Pediatrics, Division of Pulmonology, Allergy, Immunology and Infectious Diseases, Rutgers New Jersey Medical School; Clinical Director, Francois-Xavier Bagnold Center for Children, University Hospital

Arry Dieudonne, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Chief Editor

Russell W Steele, MD Clinical Professor, Tulane University School of Medicine; Staff Physician, Ochsner Clinic Foundation

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, Southern Medical Association

Disclosure: Nothing to disclose.


David F Butler, MD Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Rosalie Elenitsas, MD Herman Beerman Associate Professor of Dermatology, University of Pennsylvania School of Medicine; Director, Penn Cutaneous Pathology Services, Department of Dermatology, University of Pennsylvania Health System

Rosalie Elenitsas, MD is a member of the following medical societies: American Academy of Dermatology and American Society of Dermatopathology

Disclosure: Lippincott Williams Wilkins Royalty Textbook editor; DLA Piper Consulting fee Consulting

Janet Fairley, MD Professor and Head, Department of Dermatology, University of Iowa, Roy J and Lucille A Carver College of Medicine

Janet Fairley, MD is a member of the following medical societies: American Academy of Dermatology, American Dermatological Association, American Federation for Medical Research, and Society for Investigative Dermatology

Disclosure: Nothing to disclose.

Aracelis D Fernandez, MD, FAAP Attending Physician, Assistant Professor of Pediatrics, Assistant Professor of Immunology an, Department of Pediatrics, Children's Hospital at Albany Medical Center

Aracelis D Fernandez is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Cris Jagar MD, Staff Physician, Department of Psychiatry, Trinitas Regional Medical Center

Disclosure: Nothing to disclose.

William D James, MD Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

William D James, MD is a member of the following medical societies: American Academy of Dermatology and Society for Investigative Dermatology

Disclosure: Elsevier Royalty Other

Rosemary Johann-Liang, MD Medical Officer, Infectious Diseases and Pediatrics, Division of Special Pathogens and Immunological Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration

Rosemary Johann-Liang, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Larry I Lutwick, MD Professor of Medicine, State University of New York Downstate Medical School; Director, Infectious Diseases, Veterans Affairs New York Harbor Health Care System, Brooklyn Campus

Larry I Lutwick, MD is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

José Rafael Romero, MD Director of Pediatric Infectious Diseases Fellowship Program, Associate Professor, Department of Pediatrics, Combined Division of Pediatric Infectious Diseases, Creighton University/University of Nebraska Medical Center

José Rafael Romero, MD is a member of the following medical societies: American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, New York Academy of Sciences, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Robert A Schwartz, MD, MPH Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, University of Medicine and Dentistry of New Jersey-New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

  1. Olson JG, Bourgeois AL, Fang RC, Coolbaugh JC, Dennis DT. Prevention of scrub typhus. Prophylactic administration of doxycycline in a randomized double blind trial. Am J Trop Med Hyg. 1980 Sep. 29(5):989-97. [Medline].

  2. Sharma PK, Ramakrishnan R, Hutin YJ, et al. Scrub typhus in Darjeeling, India: opportunities for simple, practical prevention measures. Trans R Soc Trop Med Hyg. 2009 Mar 13. [Medline].

  3. Watt G, Walker DH. Scrub typhus. Guerrant RL, Walker DH, Weller PF, eds. Tropical Infectious Diseases Principles, Pathogens and Practice. 2nd ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2006. Vol 1: Chapter 52.

  4. Berman SJ, Kundim WD. Scrub Typhus in South Vietnam: A Study of 87 Cases. Annals Internal Med. July 1973. 79:26-30.

  5. Corwin A, Soderquist R, Suwanabun N, Sattabongkot J, Martin L, Kelly D, et al. Scrub typhus and military operations in Indochina. Clin Infect Dis. 1999 Oct. 29(4):940-1. [Medline].

  6. Raoult D. Scrub typhus. Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, PA: Elsever Churchill Livingstone; 2005. Vol 2: 2309-10.

  7. Bavaro MF, Kelly DJ, Dasch GA, Hale BR, Olson P. History of U.S. military contributions to the study of rickettsial diseases. Mil Med. 2005 Apr. 170(4 Suppl):49-60. [Medline].

  8. Watt G, Chouriyagune C, Ruangweerayud R, Watcharapichat P, Phulsuksombati D, Jongsakul K, et al. Scrub typhus infections poorly responsive to antibiotics in northern Thailand. Lancet. 1996 Jul 13. 348(9020):86-9. [Medline].

  9. Watt G, Kantipong P, de Souza M, Chanbancherd P, Jongsakul K, Ruangweerayud R, et al. HIV-1 suppression during acute scrub-typhus infection. Lancet. 2000 Aug 5. 356(9228):475-9. [Medline].

  10. Watt G, Parola P. Scrub typhus and tropical rickettsioses. Curr Opin Infect Dis. 2003 Oct. 16(5):429-36. [Medline].

  11. Ogawa M, Hagiwara T, Kishimoto T, Shiga S, Yoshida Y, Furuya Y. Scrub typhus in Japan: epidemiology and clinical features of cases reported in 1998. Am J Trop Med Hyg. 2002 Aug. 67(2):162-5. [Medline].

  12. Lee IY, Kim HC, Lee YS, Seo JH, Lim JW, Yong TS, et al. Geographical distribution and relative abundance of vectors of scrub typhus in the Republic of Korea. Korean J Parasitol. 2009 Dec. 47(4):381-6. [Medline]. [Full Text].

  13. Hendershot EF, Sexton DJ. Scrub typhus and rickettsial diseases in international travelers: a review. Curr Infect Dis Rep. 2009 Jan. 11(1):66-72. [Medline].

  14. Shirai A, Saunders JP, Dohany AL, et al. Transmission of Scrub Typhus to Human Volunteers by Laboratory Raised Chiggers. Jpn J Med Sci Biol. 1982. 35(9):

  15. Suputtamongkol Y, Suttinont C, Niwatayakul K, et al. Epidemiology and clinical aspects of rickettsioses in Thailand. Ann N Y Acad Sci. 2009 May. 1166:172-9. [Medline].

  16. Cracco C, Delafosse C, Baril L, Lefort Y, Morelot C, Derenne JP, et al. Multiple organ failure complicating probable scrub typhus. Clin Infect Dis. 2000 Jul. 31(1):191-2. [Medline].

  17. Tseng BY, Yang HH, Liou JH, Chen LK, Hsu YH. Immunohistochemical study of scrub typhus: a report of two cases. Kaohsiung J Med Sci. 2008 Feb. 24(2):92-8. [Medline].

  18. Sonthayanon P, Chierakul W, Wuthiekanun V, Phimda K, Pukrittayakamee S, Day NP, et al. Association of high Orientia tsutsugamushi DNA loads with disease of greater severity in adults with scrub typhus. J Clin Microbiol. 2009 Feb. 47(2):430-4. [Medline]. [Full Text].

  19. Kelly DJ, Fuerst PA, Ching WM, Richards AL. Scrub typhus: the geographic distribution of phenotypic and genotypic variants of Orientia tsutsugamushi. Clin Infect Dis. 2009 Mar 15. 48 Suppl 3:S203-30. [Medline].

  20. Blacksell SD, Luksameetanasan R, Kalambaheti T, Aukkanit N, Paris DH, McGready R, et al. Genetic typing of the 56-kDa type-specific antigen gene of contemporary Orientia tsutsugamushi isolates causing human scrub typhus at two sites in north-eastern and western Thailand. FEMS Immunol Med Microbiol. 2008 Apr. 52(3):335-42. [Medline].

  21. Kweon SS, Choi JS, Lim HS, Kim JR, Kim KY, Ryu SY, et al. A community-based case-control study of behavioral factors associated with scrub typhus during the autumn epidemic season in South Korea. Am J Trop Med Hyg. 2009 Mar. 80(3):442-6. [Medline].

  22. Jensenius M, Fournier PE, Raoult D. Rickettsioses and the international traveler. Clin Infect Dis. 2004 Nov 15. 39(10):1493-9. [Medline].

  23. Matsumura Y, Shimizu T. [Case of imported scrub typhus contracted in Myanmar]. Kansenshogaku Zasshi. 2009 May. 83(3):256-60. [Medline].

  24. Liu Y, Feng D, Suo J, et al. Clinical characteristics of the autumn-winter type scrub typhus cases in south of Shandong province, northern China. BMC Infect Dis. 2009 Jun 4. 9(1):82. [Medline]. [Full Text].

  25. McGready R, Blacksell SD, Luksameetanasan R, et al. First Report of an Orientia tsutsugamushi Type TA716-Related Scrub Typhus Infection in Thailand. Vector Borne Zoonotic Dis. 2009 Jun 3. [Medline].

  26. Kramme S, An le V, Khoa ND, et al. Orientia tsutsugamushi bacteremia and cytokine levels in Vietnamese scrub typhus patients. J Clin Microbiol. 2009 Mar. 47(3):586-9. [Medline]. [Full Text].

  27. Brown GW, Robinson DM, Huxsoll DL, Ng TS, Lim KJ. Scrub typhus: a common cause of illness in indigenous populations. Trans R Soc Trop Med Hyg. 1976. 70(5-6):444-8. [Medline].

  28. Brown GW, Robinson DM, Huxsoll DL. Serological evidence for a high incidence of transmission of Rickettsia tsutsugamushi in two Orang Asli settlements in Peninsular Malaysia. Am J Trop Med Hyg. 1978 Jan. 27(1 Pt 1):121-3. [Medline].

  29. Cao M, Guo H, Tang T, Wang C, Li X, Pan X, et al. Spring scrub typhus, People's Republic of China. Emerg Infect Dis. 2006 Sep. 12(9):1463-5. [Medline].

  30. Rajapakse S, Rodrigo C, Fernando D. Scrub typhus: pathophysiology, clinical manifestations and prognosis. Asian Pac J Trop Med. 2012 Apr. 5(4):261-4. [Medline].

  31. Watt G, Jongsakul K, Chouriyagune C, Paris R. Differentiating dengue virus infection from scrub typhus in Thai adults with fever. Am J Trop Med Hyg. 2003 May. 68(5):536-8. [Medline].

  32. Wang CC, Liu SF, Liu JW, Chung YH, Su MC, Lin MC. Acute respiratory distress syndrome in scrub typhus. Am J Trop Med Hyg. 2007 Jun. 76(6):1148-52. [Medline].

  33. Chanta C, Chanta S. Clinical study of 20 children with scrub typhus at Chiang Rai Regional Hospital. J Med Assoc Thai. 2005 Dec. 88(12):1867-72. [Medline].

  34. Sirisanthana V, Puthanakit T, Sirisanthana T. Epidemiologic, clinical and laboratory features of scrub typhus in thirty Thai children. Pediatr Infect Dis J. 2003 Apr. 22(4):341-5. [Medline].

  35. Kim DM, Won KJ, Park CY, Yu KD, Kim HS, Yang TY. Distribution of eschars on the body of scrub typhus patients: a prospective study. Am J Trop Med Hyg. 2007 May. 76(5):806-9. [Medline].

  36. Lee BJ, Chen CY, Hu SY, Tsan YT, Lin TC, Wang LM. Otalgia and eschar in the external auditory canal in scrub typhus complicated by acute respiratory distress syndrome and multiple organ failure. BMC Infect Dis. 2011 Mar 30. 11:79. [Medline]. [Full Text].

  37. Edwards MS, Feigen RD. Rickettsial and Erlichial Diseases. Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 6th ed. Philadelphia, PA: Elsevier Saunders; 2009. Vol 2: 2677-2678.

  38. Sittiwangkul R, Pongprot Y, Silviliarat S, Oberdorfer P, Jittamala P, Sirisanthana V. Acute fulminant myocarditis in scrub typhus. Ann Trop Paediatr. 2008 Jun. 28(2):149-54. [Medline].

  39. Aronoff DM, Watt G. Prevalence of relative bradycardia in Orientia tsutsugamushi infection. Am J Trop Med Hyg. 2003 Apr. 68(4):477-9. [Medline].

  40. Kim DM, Kim SW, Choi SH, Yun NR. Clinical and laboratory findings associated with severe scrub typhus. BMC Infect Dis. 2010 Apr 30. 10:108. [Medline]. [Full Text].

  41. McGready R, Ashley EA, Wuthiekanun V, Tan SO, Pimanpanarak M, Viladpai-Nguen SJ, et al. Arthropod borne disease: the leading cause of fever in pregnancy on the Thai-Burmese border. PLoS Negl Trop Dis. 2010 Nov 16. 4(11):e888. [Medline]. [Full Text].

  42. McGready R, Prakash JA, Benjamin SJ, Watthanaworawit W, Anantatat T, Tanganuchitcharnchai A, et al. Pregnancy outcome in relation to treatment of murine typhus and scrub typhus infection: a fever cohort and a case series analysis. PLoS Negl Trop Dis. 2014 Nov. 8 (11):e3327. [Medline].

  43. Boggs W. Poor Pregnancy Outcomes With Murine Typhus and Scrub Typhus Infection. Reuters Health Information. Available at December 02, 2014; Accessed: October 2, 2015.

  44. Tsai CC, Chiang DH, Duh RW. Scrub typhus mimicking deep neck infection. Intern Med. 2008. 47(22):1997-2000. [Medline].

  45. Liu YX, Feng D, Zhang Q, Jia N, Zhao ZT, De Vlas SJ, et al. Key differentiating features between scrub typhus and hemorrhagic fever with renal syndrome in northern China. Am J Trop Med Hyg. 2007 May. 76(5):801-5. [Medline].

  46. Chanta C, Triratanapa K, Ratanasirichup P, Mahaprom W. Hepatic dysfunction in pediatric scrub typhus: role of liver function test in diagnosis and marker of disease severity. J Med Assoc Thai. 2007 Nov. 90(11):2366-9. [Medline].

  47. Phimda K, Hoontrakul S, Suttinont C, Chareonwat S, Losuwanaluk K, Chueasuwanchai S. Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus. Antimicrob Agents Chemother. 2007 Sep. 51(9):3259-63. [Medline].

  48. Phetsouvanh R, Blacksell SD, Jenjaroen K, Day NP, Newton PN. Comparison of indirect immunofluorescence assays for diagnosis of scrub typhus and murine typhus using venous blood and finger prick filter paper blood spots. Am J Trop Med Hyg. 2009 May. 80(5):837-40. [Medline].

  49. Koh GC, Maude RJ, Paris DH, Newton PN, Blacksell SD. Diagnosis of scrub typhus. Am J Trop Med Hyg. 2010 Mar. 82(3):368-70. [Medline]. [Full Text].

  50. Silpasakorn S, Srisamut N, Ekpo P, Zhang Z, Chao CC, Ching WM, et al. Development of new, broadly reactive, rapid IgG and IgM lateral flow assays for diagnosis of scrub typhus. Am J Trop Med Hyg. 2012 Jul. 87(1):148-52. [Medline]. [Full Text].

  51. Paris DH, Aukkanit N, Jenjaroen K, Blacksell SD, Day NP. A highly sensitive quantitative real-time PCR assay based on the groEL gene of contemporary Thai strains of Orientia tsutsugamushi. Clin Microbiol Infect. 2009 May. 15(5):488-95. [Medline].

  52. Park HS, Lee JH, Jeong EJ, Kim JE, Hong SJ, Park TK, et al. Rapid and simple identification of Orientia tsutsugamushi from other group rickettsiae by duplex PCR assay using groEL gene. Microbiol Immunol. 2005. 49(6):545-9. [Medline].

  53. Lee SH, Kim DM, Cho YS, Yoon SH, Shim SK. Usefulness of eschar PCR for diagnosis of scrub typhus. J Clin Microbiol. 2006 Mar. 44(3):1169-71. [Medline]. [Full Text].

  54. Cao M, Guo H, Tang T, Wang C, Li X, Pan X, et al. Preparation of recombinant antigen of O. tsutsugamushi Ptan strain and development of rapid diagnostic reagent for scrub typhus. Am J Trop Med Hyg. 2007 Mar. 76(3):553-8. [Medline].

  55. Chen HC, Chang HC, Chang YC, Liu SF, Su MC, Huang KT, et al. Chest radiographic presentation in patients with scrub typhus. Trans R Soc Trop Med Hyg. 2012 Jan. 106(1):48-53. [Medline].

  56. Jeong YJ, Kim S, Wook YD, Lee JW, Kim KI, Lee SH. Scrub typhus: clinical, pathologic, and imaging findings. Radiographics. 2007 Jan-Feb. 27(1):161-72. [Medline].

  57. Gupta N, Mittal V, Gurung B, Sherpa U. Pediatric Scrub typhus in South Sikkim. Indian Pediatr. 2012 Apr. 49(4):322-4. [Medline].

  58. Ariyoshi K, Whittle H. HIV-1 viral load and scrub typhus. Lancet. 2000 Nov 18. 356(9243):1766; author reply 1766-7. [Medline].

  59. Tsai CC, Lay CJ, Wang CL, Ho YH, Wang LS, Chen LK. Levofloxacin versus tetracycline antibiotics for the treatment of scrub typhus. Int J Infect Dis. 2009 Jun 3. [Medline].

  60. Rajapakse S, Rodrigo C, Fernando SD. Drug treatment of scrub typhus. Trop Doct. 2011 Jan. 41(1):1-4. [Medline].

  61. Watt G, Kantipong P, Jongsakul K, Watcharapichat P, Phulsuksombati D, Strickman D. Doxycycline and rifampicin for mild scrub-typhus infections in northern Thailand: a randomised trial. Lancet. 2000 Sep 23. 356(9235):1057-61. [Medline].

  62. Lee KY, Lee HS, Hong JH, Hur JK, Whang KT. Roxithromycin treatment of scrub typhus (tsutsugamushi disease) in children. Pediatr Infect Dis J. 2003 Feb. 22(2):130-3. [Medline].

  63. Kim DM, Yu KD, Lee JH, Kim HK, Lee SH. Controlled trial of a 5-day course of telithromycin versus doxycycline for treatment of mild to moderate scrub typhus. Antimicrob Agents Chemother. 2007 Jun. 51(6):2011-5. [Medline]. [Full Text].

  64. Mathai E, Rolain JM, Verghese GM, Abraham OC, Mathai D, Mathai M. Outbreak of scrub typhus in southern India during the cooler months. Ann N Y Acad Sci. 2003 Jun. 990:359-64. [Medline].

  65. Kim YS, Lee HJ, Chang M, Son SK, Rhee YE, Shim SK. Scrub typhus during pregnancy and its treatment: a case series and review of the literature. Am J Trop Med Hyg. 2006 Nov. 75(5):955-9. [Medline].

  66. Chung MH, Lee JS, Baek JH, Kim M, Kang JS. Persistence of Orientia tsutsugamushi in humans. J Korean Med Sci. 2012 Mar. 27(3):231-5. [Medline]. [Full Text].

  67. Rodkvamtook W, Prasartvit A, Jatisatienr C, Jatisatienr A, Gaywee J, Eamsobhana P. Efficacy of plant essential oils for the repellents against chiggers (Leptotrombidium imphalum) vector of scrub typhus. J Med Assoc Thai. 2012 May. 95 Suppl 5:S103-6. [Medline].

  68. Chattopadhyay S, Richards AL. Scrub typhus vaccines: past history and recent developments. Hum Vaccin. 2007 May-Jun. 3(3):73-80. [Medline].

  69. Valbuena G, Walker DH. Approaches to vaccines against Orientia tsutsugamushi. Front Cell Infect Microbiol. 2012. 2:170. [Medline]. [Full Text].

Transmission electron micrograph depicts peritoneal mesothelial cell of mouse that had been experimentally infected intraperitoneally with Orientia tsutsugamushi. Several organisms are visible within mesothelial cell's cytoplasm.
Eschar on neck.
Eschar on scrotum.
Typical eschar.
Maculopapular rash.
Chigger. Image taken from "Food and Environmental Hygiene Department" Web site and is reproduced under license from the Government of Hong Kong Special Administrative Region.
Medscape Consult